The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
Related Articles

News
Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer
April 22, 2019
sandiegobiotech
News
Comments Off on Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation
January 3, 2019
sandiegobiotech
Uncategorized
Comments Off on An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

News
Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth
March 13, 2019
sandiegobiotech
News
Comments Off on Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth